These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22921839)

  • 1. Fatty acids as therapeutic auxiliaries for oral and parenteral formulations.
    Hackett MJ; Zaro JL; Shen WC; Guley PC; Cho MJ
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1331-9. PubMed ID: 22921839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Delivery system design for improvement of intestinal absorption of peptide drugs].
    Muranishi S
    Yakugaku Zasshi; 1997 Jul; 117(7):394-414. PubMed ID: 9261212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 4. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
    Cai Z; Wang Y; Zhu LJ; Liu ZQ
    Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.
    Franco V; Gershkovich P; Perucca E; Bialer M
    Clin Pharmacokinet; 2020 Dec; 59(12):1493-1500. PubMed ID: 32785853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The lipid metabolism of the small intestine and its correlation to the lipid and lipoprotein metabolism of the total organism].
    Gangl A
    Acta Med Austriaca Suppl; 1975; 2():1-49. PubMed ID: 1065179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs.
    Park JW; Kim SJ; Kwag DS; Kim S; Park J; Youn YS; Bae YH; Lee ES
    Curr Pharm Des; 2015; 21(22):3097-110. PubMed ID: 26027575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches towards enhanced transepithelial drug delivery.
    Majumdar S; Mitra AK
    Discov Med; 2006 Dec; 6(36):229-33. PubMed ID: 17250788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based drug carriers for prodrugs to enhance drug delivery.
    Zaro JL
    AAPS J; 2015 Jan; 17(1):83-92. PubMed ID: 25269430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?
    Diab R; Jaafar-Maalej C; Fessi H; Maincent P
    AAPS J; 2012 Dec; 14(4):688-702. PubMed ID: 22767270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different aliphatic acid grafted N-trimethyl chitosan surface-modified nanostructured lipid carriers for improved oral kaempferol delivery.
    Du Q; Chen J; Yan G; Lyu F; Huang J; Ren J; Di L
    Int J Pharm; 2019 Sep; 568():118506. PubMed ID: 31302169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and challenges of fatty acid conjugated therapeutics.
    Bhat M; Jatyan R; Mittal A; Mahato RI; Chitkara D
    Chem Phys Lipids; 2021 May; 236():105053. PubMed ID: 33484709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex Interplay Between Solubilization, Digestion, Supersaturation and Absorption of Poorly Soluble Drugs with Lipid-Based Formulations.
    Jannin V
    Curr Drug Deliv; 2018; 15(6):749-751. PubMed ID: 29046150
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
    Talegaonkar S; Bhattacharyya A
    AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of positively charged liposaccharide derivatives as oral absorption enhancers for the delivery of anionic drugs.
    Bergeon JA; Ziora ZM; Abdelrahim AS; Pernevi NU; Moss AR; Toth I
    J Pharm Sci; 2010 May; 99(5):2333-42. PubMed ID: 19911429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting intestinal transporters for optimizing oral drug absorption.
    Varma MV; Ambler CM; Ullah M; Rotter CJ; Sun H; Litchfield J; Fenner KS; El-Kattan AF
    Curr Drug Metab; 2010 Nov; 11(9):730-42. PubMed ID: 21189135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.